Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT07497776

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose supportive care
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
National Institute of Kidney Disease and Urology (NIKDU) (from the registry)
Registry
  • NCT NCT07497776
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Bangladesh (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07497776. Non-randomized; no masking; primary purpose supportive care. Start 2024-01-27 (actual); primary completion 2025-08-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome
Condition
Dyslipidaemia
Intervention (Drug)
Atorvastatin
Lead sponsor
National Institute of Kidney Disease and Urology (NIKDU) (class: other)

Record details

Record id
cardio:ct-nct07497776
Content hash
ed9ca9844622d8c8b929402ae07ae5d5f795792649fd973aecb2209c69f26af5